Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.15 USD
+0.02 (1.77%)
Updated Jun 21, 2024 04:00 PM ET
After-Market: $1.14 -0.01 (-0.87%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.19 | 8.11% |
Earnings Summary
For their last quarter, Aclaris Therapeutics (ACRS) reported earnings of -$0.24 per share, beating the Zacks Consensus Estimate of $-0.28 per share. This reflects a positive earnings surprise of 14.29%. Look out for ACRS's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 54.76%.
Earnings History
Price & Consensus
Zacks News for ACRS
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates
ACRS: What are Zacks experts saying now?
Zacks Private Portfolio Services